H.R. 9387 aims to amend the Federal Food, Drug, and Cosmetic Act to require accurate labeling of lab-created butter. This legislation is intended to ensure that consumers have clear and truthful information about the products they are purchasing, allowing them to make informed choices regarding their food.
Supporters of H.R. 9387 have praised the bill for promoting transparency in food labeling. They argue that it empowers consumers by providing them with the necessary information to make informed dietary choices, thereby fostering trust in food products and manufacturers.
Critics of H.R. 9387 have expressed concerns that the bill may unnecessarily stigmatize lab-created butter products, potentially impacting innovation in food technology. Some argue that the labeling requirements could lead to confusion among consumers rather than clarity, and may create an unfair disadvantage for producers of lab-created butter.
The analysis of H.R. 9387, which aims to amend the Federal Food, Drug, and Cosmetic Act regarding lab-created butter labeling, reveals no direct industry overlaps between the sponsor Tony Wied's top donor industries and the bill's subject matter. The top donor industries do not appear to have a vested interest in the labeling of lab-created butter, suggesting that there is minimal risk of conflicts of interest. While there is lobbying activity in related policy areas, such as contributions from Altria Client Services and the American College of Clinical Pharmacy, these entities do not directly correlate with the bill's focus on consumer choice in butter labeling. Therefore, the potential for undue influence or conflicts of interest remains low, and voters can be reassured that the bill is unlikely to serve the interests of specific donors over the public good.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| AMERICAN COLLEGE OF CLINICAL PHARMACY | AMERICAN COLLEGE OF CLINICAL PHARMACY | $144,981 |
| ALTRIA CLIENT SERVICES | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | $40,000 |
| CROHN'S & COLITIS FOUNDATION | CROHN'S & COLITIS FOUNDATION | $40,000 |
| GOTRIANGLE | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | $30,000 |
| AFRICAN AMERICAN ALLIANCE OF CDFI CEOS | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | $20,000 |
| BRISTOL MYERS SQUIBB | ALEXANDER J. BECKLES, L.L.C. | $20,000 |
| CITY OF GLADEWATER, TEXAS | LONE STAR CONSULTING, LLC | $12,000 |
| CITY OF CRANDALL, TEXAS | LONE STAR CONSULTING, LLC | $10,000 |
| CITY OF JUSTIN, TEXAS | LONE STAR CONSULTING, LLC | $10,000 |
| THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES | MAGILL ASSOCIATES, LLC | undisclosed |
| OPPORTUNITIES INDUSTRIALIZATION CENTER OF AMERICA, INC. | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | undisclosed |
| LUMBEE TRIBE HOLDINGS, INC. | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | undisclosed |
| CITY OF CLEVELAND, TEXAS | LONE STAR CONSULTING, LLC | undisclosed |
| CITY OF RIO HONDO, TEXAS | LONE STAR CONSULTING, LLC | undisclosed |
| HOWARD COUNTY, TEXAS | LONE STAR CONSULTING, LLC | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Tony Wied, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
